Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bliss GVS Pharma Limited Share Issue/Capital Change 2024

Jun 10, 2024

61284_rns_2024-06-10_1aec567a-4d17-46c0-99a2-ee7cafabb423.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [425 x 39] intentionally omitted <==

June 10, 2024

To
The Manager, Listing Department
National Stock Exchange of India Ltd.
Plot no. C/1 G Block,
Bandra-Kurla Complex, Bandra (East),
Mumbai- 400 051
Symbol:BLISSGVS
To
The General Manager, Listing Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai- 400 001
ScripCode:506197

Dear Sir/Madam,

– Subject: Allotment of Shares under Bliss GVS Pharma Limited Employee Stock Options Plan, 2019

We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on June 10, 2024, has approved the allotment of 1,45,000 equity shares of the face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited–Employee Stock Option Plan 2019 (‘Bliss GVS ESOP-2019’).

Consequent to the aforesaid allotment, issued, subscribed & paid-up share capital of the Company has increased as under:


Company has increased as under:
From To
10,47,37,573 equity shares of Re. 1/- each
aggregating Rs. 10,47,37,573/-
10,48,82,572 equity shares of Re. 1/- each
aggregating Rs. 10,48,82,572 /-

In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 the details of shares allotted as above are given in ‘Annexure-I’ to this intimation.

Kindly take the above information on record.

Thank you. Yours Faithfully,

For Bliss GVS Pharma Limited

ADITI Digitally signed by ADITI HIMANSHU HIMANSHU BHATT Date: 2024.06.10 BHATT 19:34:52 +05'30' Aditi Bhatt Company Secretary

Encl: As above

==> picture [425 x 62] intentionally omitted <==

==> picture [425 x 39] intentionally omitted <==

‘Annexure – I’

Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

==> picture [425 x 553] intentionally omitted <==

----- Start of picture text -----

Company Name and address of Registered Bliss GVS Pharma Limited
Office Add: 102, Hyde Park, Saki Vihar Road,
Andheri (East), Mumbai - 400072
Name of the Stock Exchanges on which the BSE Limited
Company’s shares are listed The National Stock Exchange of India
Limited
Filing date of the statement referred in 14/02/2020
regulation 10(b) of the SEBI (Share Based
Employee Benefits) Regulations, 2014 read
with the SEBI (Share Based Employee
Benefits and Sweat Equity) Regulations,
2021 with the recognized Stock Exchange
Filing Number, if any Application No:
BSE – 106063
NSE – 23188
In-Principle Approval Letter:
BSE: DCS/FL/DS/ESOP-IP/542/2019-20
dated February 27, 2020
NSE: NSE/LIST/23188 dated March 04,
2020
Title of the Scheme pursuant to which Bliss GVS Pharma Limited–Employee Stock
shares are issued, if any Option Plan, 2019
Kind of security to be listed Equity Shares
Par value of the shares Re. 1/- per share
Date of issue of shares June 10, 2024
Number of shares issued 1,45,000
Share Certificate No., if applicable Not Applicable
Distinctive number of the share, if 10,47,37,573 to 10,48,82,572 (both inclusive)
applicable
ISIN Number of the shares if issued in INE416D01022
Demat
Exercise price per share Rs. 43/- per share
Premium per share Rs. 42/- per share
Total Issued shares after this issue 10,48,82,572
----- End of picture text -----

==> picture [425 x 62] intentionally omitted <==

==> picture [425 x 39] intentionally omitted <==

==> picture [425 x 186] intentionally omitted <==

----- Start of picture text -----

Total Issued share capital after this issue Rs. 10,48,82,572 /-
Details of any lock-in on the shares as per Lock in for a period of 6 (six) months from
the date of allotment of Equity Shares.
Date of expiry of lock-in December 10, 2024
Whether shares identical in all respects to All equity shares of the Company allotted
existing shares if not, when will they pursuant to the exercise of stock options
become identical? shall rank pari-passu with the existing
equity shares of the Company
Details of listing fees, if payable Not applicable
----- End of picture text -----

==> picture [425 x 62] intentionally omitted <==